Skip to main content

683 Capital Management, LLC

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 1404574 NEW YORK, NY

Position in FOLD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$11,206,500
-$185,500 QoQ
Shares Held
775,000
-3.1% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FOLD Over Time

Shares Held

Position Value (USD)

Derivatives in FOLD

reported options exposure · as of Dec 31, 2023
CallValue
$4,193,145
CallShares
295,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

683 Capital Management, LLC holds $329,314,446 across 63 Biotechnology names. FOLD ranks #9 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FOLD

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,206,500 775,000
2025-12-31 $11,392,000 800,000
2025-09-30 $6,579,800 835,000
2025-06-30 $5,500,800 960,000
2025-03-31 $2,244,000 275,000
2023-12-31 $4,193,145 295,500